Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.18
-0.51 (-0.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
Utah Medical Products Market Cap
Utah Medical Products has a market cap or net worth of $217.67 million as of November 21, 2024. Its market cap has decreased by -25.04% in one year.
Market Cap
217.67M
Enterprise Value
129.52M
1-Year Change
-25.04%
Ranking
Category
Stock Price
$64.18
Market Cap Chart
Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $217.67M, an increase of 341.53%. That is a compound annual growth rate of 5.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 219.40M | -28.23% |
Dec 29, 2023 | 305.70M | -16.18% |
Dec 30, 2022 | 364.70M | -0.11% |
Dec 31, 2021 | 365.10M | 18.96% |
Dec 31, 2020 | 306.90M | -23.56% |
Dec 31, 2019 | 401.50M | 29.43% |
Dec 31, 2018 | 310.20M | 2.41% |
Dec 29, 2017 | 302.90M | 10.71% |
Dec 30, 2016 | 273.60M | 24.65% |
Dec 31, 2015 | 219.50M | -2.36% |
Dec 31, 2014 | 224.80M | 5.15% |
Dec 31, 2013 | 213.80M | 60.99% |
Dec 31, 2012 | 132.80M | 35.10% |
Dec 30, 2011 | 98.30M | 1.13% |
Dec 31, 2010 | 97.20M | -8.13% |
Dec 31, 2009 | 105.80M | 25.95% |
Dec 31, 2008 | 84.00M | -27.84% |
Dec 31, 2007 | 116.40M | -10.67% |
Dec 29, 2006 | 130.30M | 5.59% |
Dec 30, 2005 | 123.40M | 33.55% |
Dec 31, 2004 | 92.40M | -23.38% |
Dec 31, 2003 | 120.60M | 28.30% |
Dec 31, 2002 | 94.00M | 37.43% |
Dec 31, 2001 | 68.40M | 81.43% |
Dec 29, 2000 | 37.70M | -13.53% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Inogen | 225.32M |
Zentalis Pharmaceuticals | 223.06M |
biote | 220.19M |
Sutro Biopharma | 220.16M |
TScan Therapeutics | 219.89M |
High Tide | 213.72M |
Trevi Therapeutics | 212.92M |
Genfit | 211.03M |